[Experimental study on protective effect of small interfering RNA-induced Atrogin-1 gene silencing on muscle cell

Lei Yuan1, Guo-Hao Wu, Bo Zhang

  • 1Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Abstract

Insights

Silencing the Atrogin-1 gene protects muscle cells from malnutrition induced by TNF-alpha. This suggests Atrogin-1 is a potential therapeutic target for conditions like cancer cachexia.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Muscle cell malnutrition is a significant health concern, often linked to conditions like cancer cachexia.
  • Atrogin-1 plays a crucial role in muscle protein degradation and atrophy.

Purpose of the Study:

  • To investigate the protective effect of Atrogin-1 gene silencing on muscle cells experiencing malnutrition.
  • To assess the efficacy of RNA interference (RNAi) in modulating Atrogin-1 expression.

Main Methods:

  • Synthesized and cloned Atrogin-1 siRNA sequences into lentiviral vectors.
  • Transfected 293T cells to package lentivirus, then infected C2C12 myotubes.
  • Induced muscle cell malnutrition using TNF-alpha and analyzed Atrogin-1 expression via real-time PCR and Western blot.

Main Results:

  • Successfully constructed and validated recombinant lentiviral vectors for Atrogin-1 gene silencing.
  • TNF-alpha treatment led to significant myotube atrophy and increased Atrogin-1 expression in control groups.
  • Atrogin-1 gene silencing significantly inhibited TNF-alpha-induced muscle cell malnutrition.

Conclusions:

  • Atrogin-1 gene silencing effectively mitigates muscle cell malnutrition induced by TNF-alpha.
  • Targeting Atrogin-1 presents a promising therapeutic strategy for muscle wasting diseases, including cancer cachexia.